Form 8-K IDEXX LABORATORIES INC For: Jul 25

Go back to Form 8-K IDEXX LABORATORIES INC For: Jul 25

IDEXX Labs (IDXX) Tops Q2 EPS by 5c; Approves Buyback; Guides FY14

July 25, 2014 8:00 AM EDT

IDEXX Labs (NASDAQ: IDXX) reported Q2 EPS of $1.10, $0.05 better than the analyst estimate of $1.05. Revenue for the quarter came in at $390 million versus the consensus estimate of $385.2 million.

IDEXX Labs sees FY2014 EPS of $3.79 - $3.86, versus the consensus of $3.84. IDEXX Labs sees FY2014 revenue of $1.51 - $1.52 billion, versus the consensus of $1.50 billion.

Increase in Share Repurchase Program

The IDEXX Board of Directors has authorized the repurchase by the Company of up to an additional five million shares of its common stock under its ongoing share repurchase program. Repurchases... More